Shops lining up to win SmithKline's $25 mil Paxil

Published on .

Several agencies are competing for the upcoming, estimated $25 million account for anti-depressant prescription drug Paxil from SmithKline Beecham. McCann-Erickson Worldwide and Jordan McGrath Case & Partners, both New York; and WPP Group's CommonHealth USA, Parsippany, N.J., are in the running to market the drug, which is still awaiting approval from the Food & Drug Administration.

Copyright July 1998, Crain Communications Inc.

Most Popular
In this article: